Viewing Study NCT00630994

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:35 AM
Ignite Modification Date: 2026-05-20 @ 5:32 PM
Study NCT ID: NCT00630994
Status: TERMINATED
Last Update Posted: 2015-12-30
First Post: 2008-03-06
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloproliferative Disorders View
None Secondary Myelofibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None primary myelofibrosis View
None secondary myelofibrosis View
None essential thrombocythemia View
None polycythemia vera View